Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study
2009; Springer Science+Business Media; Volume: 117; Issue: 3 Linguagem: Inglês
10.1007/s00702-009-0344-4
ISSN1435-1463
AutoresKarla Eggert, Örjan Skogar, Khaled Amar, Liisa Luotonen, Mikko Kuoppamäki, Mika Leinonen, Helena Nissinen, Wolfgang H. Oertel,
Tópico(s)Attention Deficit Hyperactivity Disorder
Referência(s)